Nanostructured surfaces for biomedical/biomaterial applications and processes thereof
Inventors
Robeson, Lloyd Mahlon • Rothrock, Ginger Denison
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
A medical device includes a textured surface having a predetermined nanostructure, wherein the nanostructure is less than about 500 nanometers in a broadest dimension. The textures nanostructure surface reduces friction between the medical device and biological tissue.
Core Innovation
The invention relates to nano-structured biomedical device surfaces and nano-structures for medical applications. The mold has a first surface defining nano-structures configured for fabricating medical articles for treating biologic tissues or conditions, and the nano-structures are less than 500 nm in a dimension.
The mold comprises an oligomer produced from polymerization of specified fluorinated monomers and a functional monomer. The fluorinated monomers include trifluorochloroethylene, trifluoroethylene, hexafluoro-iso-propyl (meth)acrylate, 1H,1H,3H-hexafluorobutyl(meth)acrylate, 1H,1H,5H-octafluoropentyl (meth)acrylate, pentafluorophenyl (meth)acrylate, perfluoro(methyl vinyl ether), 1,1-dihydroperfluorobutyl (meth)acrylate, and combinations thereof, and the functional monomer is selected from hydroxyethyl(meth)acrylate, (meth)acrylic acid, vinyl acetate, vinyl sulfonic acid, styrene sulfonic acid, 4-hydroxy styrene, 2-acrylamido-2-methyl propane sulfonate, maleic anhydride, glycidyl methacrylate, isocyanatoethyl methacrylate, and combinations thereof.
A related aspect is a system for fabricating nano-structures for medical applications. The system includes the mold and a biomaterial configured to be molded by the mold to form a medical article that treats or prevents a biologic tissue or condition.
Claims Coverage
The independent claims cover a mold and a system. Across the claims, two primary inventive features are defined: nano-structures less than 500 nm in a dimension, and a mold material comprising an oligomer from specified fluorinated monomers plus a selected functional monomer, with the system additionally requiring a biomaterial.
Nano-structures less than 500 nm in a dimension
A mold having a first surface defining nano-structures for fabricating medical articles for treating biologic tissues or conditions, wherein the nano-structures are less than 500 nm in a dimension.
Fluorinated oligomer mold material with selected functional monomer
The mold comprises an oligomer produced from polymerization of specified fluorinated monomers and a functional monomer selected from hydroxyethyl(meth)acrylate, (meth)acrylic acid, vinyl acetate, vinyl sulfonic acid, styrene sulfonic acid, 4-hydroxy styrene, 2-acrylamido-2-methyl propane sulfonate, maleic anhydride, glycidyl methacrylate, isocyanatoethyl methacrylate, and combinations thereof.
System with mold and biomaterial configured to form treating or preventing medical article
A system comprising a mold with a first surface defining nano-structures for molding articles therefrom, wherein the nano-structures are less than 500 nm in a dimension, and a biomaterial configured to be molded by the mold to form a medical article that treats or prevents a biologic tissue or condition.
The claims center on a nano-structured mold below 500 nm in a dimension made from an oligomer of defined fluorinated monomers plus a defined functional monomer. The system claim adds a biomaterial molded by that mold to form a medical article configured to treat or prevent a biologic tissue or condition.
Stated Advantages
Strong adhesion/mechanical properties are stated for UV-thermal dual cure systems.
Documented Applications
Mold replication to create PFPE-DMA replicas of animal tissues/vessels is described, with confirmation using microscopy.
UV templating to generate templates/replicas of adenovirus and hemoglobin proteins is described, with microscopy/SEM/TEM confirmation.
Interested in licensing this patent?